CT Clinical Research /ID# 253488 — Cromwell, Connecticut

CT Clinical Research /ID# 253488 is a clinical research site located in Cromwell, Connecticut, United States 06416.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

CT Clinical Research /ID# 253488 has participated in 1 clinical trials.

Therapeutic areas: Bipolar I Disorder.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cromwell

Browse all research sites in Connecticut · View every site in Cromwell

• CT Clinical Research
• Connecticut Clinical Research
• Clinical Research Site
• Oruka Therapeutics Investigative Site
• Connecticut Clinical Research - Cromwell
• Pfizer Investigational Site
• Tonix Clinical Site
• Central Connecticut Dermatology
• CCD Research, PLLC /ID# 240728
• Forest Investigative Site 034
• Neurocrine Clinical Site
• Cara Therapeutics Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CT Clinical Research /ID# 253488?

CT Clinical Research /ID# 253488 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CT Clinical Research /ID# 253488 conducted?

CT Clinical Research /ID# 253488 has 1 clinical trials on record. Their work covers Bipolar I Disorder.

Is CT Clinical Research /ID# 253488 accredited by Crixeo Clinical Trials?

CT Clinical Research /ID# 253488 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CT Clinical Research /ID# 253488?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.